What is Shore Imaging?
Operating for over two decades, Shore Imaging has established itself as a cornerstone of the Lakewood and Whiting healthcare communities. The firm specializes in a comprehensive suite of diagnostic modalities, including high-resolution MRI, CT scanning, and specialized 3D digital mammography. By prioritizing patient-centric care and offering expedited same-day scheduling, the company differentiates itself in a competitive landscape. Their focus on early detection protocols for oncology—specifically breast and lung cancer—positions them as a critical partner for both local patients and referring physicians seeking reliable, high-quality diagnostic outcomes.
How much funding has Shore Imaging raised?
Shore Imaging has raised a total of $317K across 2 funding rounds:
Debt
$150K
Debt
$167K
Debt (2020): $150K with participation from PPP
Debt (2021): $167K led by PPP
Key Investors in Shore Imaging
PPP
Public-Private Partnership
What's next for Shore Imaging?
With this late-stage capital, Shore Imaging is well-positioned to scale its diagnostic capabilities and potentially expand its footprint within the New Jersey healthcare market. The strategic allocation of these funds will likely focus on upgrading existing imaging hardware to the latest technological standards, thereby enhancing diagnostic precision and throughput. As the company navigates its next phase of growth, the emphasis will remain on maintaining its reputation for clinical excellence while optimizing operational efficiencies to meet the evolving needs of the regional healthcare ecosystem. Future initiatives may include further integration of AI-driven diagnostic tools to support radiologists in early-stage disease identification.
See full Shore Imaging company page
